Pharmacology and Therapeutics

Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling
Stacey S Cherny, Daniel Nevo, Avi Baraz, Shoham Baruch, Ohad Lewin-Epstein, Gideon Y Stein, Uri Obolski

medRxiv 2020.07.02.20144006; doi: https://doi.org/10.1101/2020.07.02.20144006

Add to Selected Citations
FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages
Aleah R. Hunt, Shawn N. Coffeen, Dane L. Shiltz, Calvin Ice, Jessica Parker

medRxiv 2020.08.19.20178061; doi: https://doi.org/10.1101/2020.08.19.20178061

Add to Selected Citations
A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin
Juan Kou, Yingying Zhang, Feng Zhou, Cornelia Sindermann, Christian Montag, Benjamin Becker, Keith M Kendrick

medRxiv 2020.08.23.20180489; doi: https://doi.org/10.1101/2020.08.23.20180489

Add to Selected Citations
Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer
Hai-ni Wen, Yi-xi Liu, Da Xu, Kai-jing Zhao, Zheng Jiao

medRxiv 2020.08.23.20179655; doi: https://doi.org/10.1101/2020.08.23.20179655

Add to Selected Citations
Model-based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans
Can Liu, Vivaswath S. Ayyar, Xirong Zheng, Wenbo Chen, Songmao Zheng, Hardik Mody, Weirong Wang, Donald Heald, Aman P. Singh, Yanguang Cao

medRxiv 2020.05.09.20096586; doi: https://doi.org/10.1101/2020.05.09.20096586

Add to Selected Citations
Efficacy of Tocilizumab in Covid 19: A metanalysis of case series studies
Shalam Mohamed Hussain, Ayesha Farhana Syeda, Osama Al-Wutayd, Abdullah Al Nafeesah, Mohammad Alshammari, Sulaiman Alnasser, Nandakumar Krishnadas

medRxiv 2020.08.12.20173682; doi: https://doi.org/10.1101/2020.08.12.20173682

Add to Selected Citations
Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations
Yonghyun Nam, Jae-Seung Yun, Seung Mi Lee, Ji Won Park, Ziqi Chen, Brian Lee, Anurag Verma, Xia Ning, Li Shen, Dokyoon Kim

medRxiv 2020.08.11.20173120; doi: https://doi.org/10.1101/2020.08.11.20173120

Add to Selected Citations
Towards safer risperidone prescribing in Alzheimer’s disease
Suzanne Reeves, Julie Bertrand, Hiroyuki Uchida, Kazunari Yoshida, Yohei Otani, Mikail Ozer, Kathy Y Liu, Elvira Bramon, Robert Bies, Bruce Pollock, Robert Howard

medRxiv 2020.08.12.20173310; doi: https://doi.org/10.1101/2020.08.12.20173310

Add to Selected Citations
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation
Xiao-qin Liu, Yi-wei Yin, Chen-yu Wang, Zi-ran Li, Xiao Zhu, Zheng Jiao

medRxiv 2020.08.10.20170795; doi: https://doi.org/10.1101/2020.08.10.20170795

Add to Selected Citations
Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial - A preliminary report
Mariano Duarte, Facundo Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Vetulli, Analía Aquieri, Francisco Azzato, Mauro Basconcel, Marcela Castro, Javier Coyle, Ignacio Davolos, Eduardo Esparza, Ignacio Fernandez Criado, Rosana Gregori, Pedro Mastrodonato, María C. Rubio, Sergio Sarquis, Fernando Wahlmann, Rodolfo P. Rothlin

medRxiv 2020.08.04.20167205; doi: https://doi.org/10.1101/2020.08.04.20167205

Add to Selected Citations

Pharmacology and Therapeutics

Pages